21 CFR 529.2620
§ 529.2620 Triptorelin.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 529.2620, § 529.2620 Triptorelin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87701
- Permanent ID
ys:prov:87701@1- SHA-256
5722f41f34b93e99d69834cc8c6cf8546b3b920242a084a53212a965abfd0e75
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each milliliter of gel contains 100 micrograms (mcg) triptorelin as triptorelin acetate.
(b) Sponsor. See No. 051072 in § 510.600(c) of this chapter.
(c) Conditions of use in swine—(1) Amount. Administer 200 mcg intravaginally approximately 96 hours after weaning.
(2) Indications for use. For the synchronization of time of insemination in weaned sows to facilitate a single fixed-time artificial insemination.
(3) Limitations. Not approved for use in gilts. Safety and effectiveness have not been evaluated in these animals. Should not be used in sows with obvious reproductive tract abnormalities.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.